Group items tagged

Ovarian Cancer Research Fund Alliance is requesting Letters of Intent for the 2017 Ann Schreiber Mentored Investigator Award. This grant provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research, or relevant area.

Through the program, the center will award grants of up to $120,000 over two years to promising laboratory and clinical scientists pursuing careers as independent investigators in ovarian cancer research. Funds are for direct costs only; institutional overhead and indirect costs will not be included in the award.

To that end, the center is inviting applications for its Pilot Study Awards. Through the program, twelve grants of $75,000 over two years will be awarded in support of new avenues of ovarian cancer research and to expand understanding of the disease, broadly defined. Projects designed to analyze data from already funded clinical trials will be considered, and there is a possibility of an additional $25,000 awarded in year two upon evaluation of year-one progress, contingent on the availability of funds. Funding priority will be given to proposals that are innovative, multidisciplinary, likely to lead to submission of grant applications for independently funded investigations, and convey translational research potential. To be eligible, applicants must be at the assistant, associate, or full professor level (or equivalent).

Woman to Woman, a program of the Ovarian Cancer Research Fund Alliance, pairs gynecologic cancer patients with trained survivor-volunteers who provide one-on-one emotional support and mentoring to women when they need it most. From the moment of diagnosis through the end of treatment, Woman to Woman survivor-volunteers have helped hundreds of women and their families cope with gynecologic cancer. Through the program, one-year grants of either $60,000 (for hospital-based programs) or $30,000 (for community-based organizations) will be awarded to institutions with a large volume of gynecologic cancer patients and a need to provide this type of support to patients. Grants are provided to cover the cost of a part-time program coordinator's salary (can be a new hire or a reassignment), program costs, and a patient fund (no indirect costs allowed). It is expected that each Woman to Woman program will become self-sustaining after the first year. OCRFA will provide all program materials for patients, as well as technical assistance and support, for the life of the program (even after the end of the grant period). Institutions and organizations also will have access to a dedicated section of the Woman to Woman website (under construction) featuring tools designed to assist them in the development and administration of new programs.

Through the program, the center will award three grants of up to $60,000 each to promising laboratory and clinical scientists interested in pursuing a career as an independent investigator in ovarian cancer research. Funds are for direct costs only; institutional overhead and indirect costs will not be included in the award.

The Rivkin Center is announcing funds for Scientific Scholar Awards to be allocated based on scientific merit. Scientific Scholar Awards are intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator in ovarian cancer research. The two-year awards will provide a total of $120,000 in funding.

The Rivkin Center is announcing funds for Pilot Study Awards to be allocated based on scientific merit. Pilot Study Awards support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. The two-year awards will provide a total of $75,000 in funding, with the possibility of an additional $25,000 awarded in year two, upon evaluation of year one progress, contingent on availability of funds.

The purpose of the Funding Opportunity Announcement (FOA) is to support pilot research projects using a "Traceback" approach to genetic testing women with a personal or family history of ovarian cancer and reaching out to family members to identify unaffected individuals at increased risk for cancer in different clinical contexts and communities, including racially/ethnically diverse populations.